Pfizer seeks booster approval for all adults

Pfizer and BioNTech on Tuesday requested the U.S. Food and Drug Administration to authorize booster doses of their COVID-19 vaccine in all adults, presenting recent data showing the shot would help prevent disease across ages. Bryan Wood reports.